Identification of necroptosis-related lncRNAs for prognosis prediction and screening of potential drugs in patients with colorectal cancer

Figure 6 Assessment of the signature in the clinical colorectal cancer cohort and the relationships between the 8 long noncoding RNAs and clinicopathological characteristics. A: The areas under the receiver operating characteristic curve (AUCs) for 1-, 2- and 3-year overall survival (OS) determined with the clinical data of colorectal cancer (CRC) patients; B: The AUCs for the risk score (RS) of 1-year OS and for clinicopathologic characteristics; C: The Kaplan-Meier survival curves for the OS of the high- and low-risk groups, which were defined by the median RS as the cutoff; D to G The relationships between the 8 long noncoding RNAs (lncRNAs) and clinicopathological characteristics in the The Cancer Genome Atlas-CRC cohort. H to K: The relationships between the 8 lncRNAs and clinicopathological characteristics in the clinical CRC cohort. AUC: Areas under the receiver operating characteristic curve; LncRNA: Long noncoding RNA.